VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PDSB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
PDSBPDS Biotechnology Corporation
$0.90$50M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksPDSBQuarterly Financials

PDS Biotechnology Corporation (PDSB) Quarterly Financials

120+ quarters historyFree accessUpdated daily

PDS Biotechnology Corporation (PDSB) quarterly income statement — complete revenue, gross profit & net income history

PDSB Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold0000015.13K00000000000000
COGS % of Revenue--------------------
Gross Profit00000-15.13K00000000000000
Gross Margin %--------------------
Gross Profit Growth %-100%------------------
Operating Expenses6.52M6.67M8.14M7.62M9.11M7.35M10.18M8.68M10.1M10.41M10.52M12.7M9.42M18.82M7.28M7.09M8.48M6.32M6.96M5.11M
OpEx % of Revenue--------------------
Selling, General & Admin3.06B2.27M3.56M3.41M3.27M2.82M3.37M4.16M3.39M2.94M4.07M4.69M3.58M2.67M2.93M3.33M3.32M2.93M3.27M2.34M
SG&A % of Revenue--------------------
Research & Development3.46M4.41M4.58M4.21M5.83M4.53M6.8M4.53M6.7M7.47M6.45M8M5.84M16.16M4.35M3.76M5.16M3.39M3.69M2.76M
R&D % of Revenue--------------------
Other Operating Expenses-1000K0000000000000000000
Operating Income-6.52M-6.67M-8.14M-7.62M-9.11M-7.36M-10.18M-8.68M-10.1M-10.41M-10.52M-12.7M-9.42M-18.82M-7.28M-7.09M-8.48M-6.32M-6.96M-5.11M
Operating Margin %--------------------
Operating Income Growth %28.38%9.32%20.03%12.22%9.82%29.27%3.24%31.6%-7.17%44.71%-44.52%-79%-11.12%-197.73%-4.55%-38.91%-178.07%-56.96%-78.2%-73.91%
EBITDA-6.52M-6.67M-8.13M-7.62M-9.1M-7.35M-10.17M-8.68M-10.09M-10.39M-10.51M-12.69M-9.42M-18.81M-7.03M-7.02M-8.48M-6.32M-6.96M-5.1M
EBITDA Margin %--------------------
EBITDA Growth %28.34%9.21%20.04%12.22%9.83%29.32%3.25%31.62%-7.15%44.75%-49.63%-80.84%-11.09%-197.59%-0.95%-37.48%-178.24%-57.09%-78.35%-74.1%
D&A (Non-Cash Add-back)05.46K5.46K5.46K5.46K15.13K5.46K5.46K4.74K14.4K4.73K4.74K3.15K11.57K00869511.27K1.27K
EBIT-6.52M-6.45M-7.86M-7.29M-8.73M-6.86M-9.51M-8.01M-9.43M-10.41M-9.78M-11.95M-8.69M-18.82M-7.03M-7.02M-8.47M-6.32M-6.96M-5.11M
Net Interest Income-827.97K-888.21K-869.27K-1.81M-553K-592K-548K-513K-506K-491K-329K-245K-238K-316.33K-145K74.55K5.7K1.73K1.36K604
Interest Income186.81K224.66K281.11K333.62K377.85K503.94K666.77K675.21K668.89K683.54K739.4K750.65K729.34K-14574.55K5.7K1.73K1.36K604
Interest Expense1.01M1.11M1.15M2.14M930.88K1.1M1.22M1.19M1.18M1.18M1.07M995.4K966.85K316.33K145.25K00000
Other Income/Expense-827.97K-888.21K-869.27K-1.81M-553.03K-591.78K-547.96K-512.76K-505.85K-491.25K-329.48K-244.74K-237.5K-316.33K-145.25K74.55K5.7K1.73K1.36K604
Pretax Income-7.35M-7.56M-9.01M-9.43M-9.66M-7.95M-10.73M-9.2M-10.6M-10.9M-10.85M-12.94M-9.66M-19.14M-7.42M-7.02M-8.47M-6.32M-6.96M-5.11M
Pretax Margin %--------------------
Income Tax0000-1.17M00-869.17K020-1.41M000-1.2M000-4.52M
Effective Tax Rate %0%0%0%0%12.11%0%0%9.45%0%-0%0%10.86%0%0%0%17.08%0%0%0%88.46%
Net Income-7.35M-7.56M-9.01M-9.43M-8.49M-7.95M-10.73M-8.33M-10.6M-10.9M-10.85M-11.53M-9.66M-19.14M-7.42M-5.82M-8.47M-6.32M-6.96M-588.93K
Net Margin %--------------------
Net Income Growth %13.43%4.9%16.01%-13.28%19.94%27.03%1.13%27.8%-9.77%43.05%-46.13%-98.22%-14%-202.81%-6.66%-888.1%-177.95%-56.95%-78.22%79.9%
Net Income (Continuing)-7.35M-7.56M-9.01M-9.43M-8.49M-7.95M-10.73M-8.33M-10.6M-10.9M-10.85M-11.53M-9.66M-19.14M-7.42M-5.82M-8.47M-6.32M-6.96M-588.93K
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.13-0.14-0.19-0.21-0.21-0.22-0.29-0.23-0.30-0.34-0.35-0.37-0.32-0.75-0.26-0.20-0.32-0.22-0.24-0.03
EPS Growth %38.1%36.36%34.48%8.7%30%35.29%17.14%37.84%6.25%54.67%-34.62%-85%0%-240.91%-8.33%-687.4%-128.57%15.38%-14.29%86.63%
EPS (Basic)-0.13-0.14-0.19-0.21-0.21-0.22-0.29-0.23-0.30-0.34-0.35-0.37-0.32-0.75-0.26-0.20-0.32-0.22-0.24-0.03
Diluted Shares Outstanding55.5M46.38M46.87M45.9M40.52M36.45M36.81M36.69M34.82M31.67M30.91M30.8M30.43M28.77M28.46M28.45M26.16M28.43M28.43M23.16M
Basic Shares Outstanding55.5M46.38M46.87M45.9M40.52M36.45M36.81M36.69M34.82M31.67M30.91M30.8M30.43M28.77M28.46M28.45M26.16M28.43M28.43M23.16M
Dividend Payout Ratio--------------------